Accessibility settings

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/86737, first published .
Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational Study

Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational Study

Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational Study

Kerstin Michalski   1, 2 , MD ;   Theo Lorenzini   3 , MD ;   Tim Jedamzik   1 ;   Marieke Heinrich   1 , MD ;   Aleksander Kosmala   1 , MD ;   Isabel Rauscher   3 , MD Prof ;   Mika Bauch   3 ;   Lena Reichl   4 ;   Luisa Amann   5 ;   Simon Liebl   4 ;   Andreas Buck   1, 2 , MD Prof ;   Matthias Eiber   2, 3 , MD Prof ;   Constantin Lapa   2, 5 , MD Prof ;   Rainer Claus   2, 4, 6 , MD Prof

1 Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany

2 Bavarian Cancer Research Center (BZKF), Erlangen, Germany

3 Department of Nuclear Medicine, School of Medicine and Health, Technical University of Munich, Munich, Germany

4 Hematology and Oncology, Faculty of Medicine, University Hospital Augsburg, Augsburg, Germany

5 Department of Nuclear Medicine, Faculty of Medicine, University Hospital Augsburg, Augsburg, Germany

6 Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany

Corresponding Author:

  • Kerstin Michalski, MD
  • Department of Nuclear Medicine
  • University Hospital Würzburg
  • Oberdürrbacher Str. 6
  • Würzburg 97080
  • Germany
  • Email: michalski_k@ukw.de